Christine Mauck Selected Research

Christine Mauck Research Topics

5	Sexually Transmitted Diseases (Sexually Transmitted Disease) 12/2012 - 04/2004
3	Bacterial Vaginosis 01/2023 - 09/2007
3	Infections 01/2019 - 01/2011
3	HIV Infections (HIV Infection) 01/2015 - 08/2006
2	HIV Seropositivity 05/2016 - 09/2015
2	Inflammation (Inflammations) 05/2016 - 08/2006
2	Candidiasis (Moniliasis) 09/2015 - 09/2007
1	Pruritus (Itching) 01/2023
1	Reproductive Tract Infections 09/2015
1	Bacterial Infections (Bacterial Infection) 09/2015
1	Gonorrhea 09/2015
1	Herpes Genitalis (Genital Herpes) 09/2015
1	Trichomonas Infections 09/2015
1	Asymptomatic Infections 09/2015
1	Communicable Diseases (Infectious Diseases) 03/2009
1	Neoplasms (Cancer) 03/2009
1	Hypersensitivity (Allergy) 12/2004
1	Chronic Disease (Chronic Diseases) 12/2004

4	Biomarkers (Surrogate Marker)IBA 05/2016 - 03/2009
3	Contraceptive Agents (Contraceptives)IBA 01/2019 - 04/2004
2	Clindamycin (Cleocin)FDA LinkGeneric 01/2023 - 01/2022
2	Vaginal Creams, Foams, and Jellies (Vaginal Tablet)IBA 01/2023 - 01/2022
2	N,N-dimethyl-4-anisidine (DMPA)IBA 01/2019 - 09/2015
2	CytokinesIBA 05/2016 - 08/2006
2	Chemokine CCL5IBA 05/2016 - 09/2015
2	Hormones (Hormone)IBA 09/2015 - 12/2004
2	UC-781IBA 11/2012 - 01/2011
1	AntigensIBA 01/2019
1	ChemokinesIBA 05/2016
1	Combined Oral ContraceptivesIBA 09/2015
1	EnzymesIBA 09/2015
1	ImmunosorbentsIBA 09/2015
1	Interleukin-6 (Interleukin 6)IBA 09/2015
1	Interleukin-8 (Interleukin 8)IBA 09/2015
1	Levonorgestrel (Plan B)FDA LinkGeneric 09/2015
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 09/2015
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 09/2015
1	GelsIBA 01/2015
1	Anti-Infective Agents (Microbicides)IBA 07/2012
1	K-Y jellyIBA 09/2007
1	Local Anti-Infective Agents (Antiseptics)IBA 08/2006

2	Hormonal Contraception 05/2016 - 09/2015
1	Intravaginal Administration 01/2023
1	Contraception (Birth Control) 09/2015
1	Injections 09/2015
1	Condoms (Condom) 12/2012
1	Therapeutics 03/2009
1	Tubal Sterilization (Tubal Ligation) 05/2006